| Prev Close | 0.48 |
| Open | 0.48 |
| Day Low/High | 0.46 / 0.50 |
| 52 Wk Low/High | 0.35 / 3.69 |
| Volume | 292.60K |
| Avg Volume | 129.60K |
| Exchange | NASDAQ |
| Shares Outstanding | 22.74M |
| Market Cap | 11.14M |
| EPS | -0.40 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
7 Stocks Under $10 Spiking Toward Big Gains
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits
GenVec Provides Update On Hearing Loss Clinical Program
Data Safety Monitoring Board Recommends Trial Continue
5 Stocks Under $10 Set to Soar Higher
These five stocks trading for less than $10 a share are within range of triggering breakout trades.
GenVec Provides Investor Update
Highlights Ongoing Initiatives Involving the AdenoVerse™ Gene Delivery Platform
A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks
Biotech stocks large and small were plummeting as 2016's painful start began to turn torturous.
GenVec Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors
Composition of Matter Protection for Proprietary Gorilla Vectors Expansion of AdenoVerse™ Platform Provides Multiple Opportunities for New Applications
GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference
Presentation Includes Emerging Data from Malaria Collaboration with NIAID
GenVec To Present At 2015 Stem Cell Meeting On The Mesa
Wednesday, October 7th, 5:15 pm Pacific/8:15 pm EDT
GenVec To Present At The Jefferies Healthcare Conference
Webcast Presentation Scheduled for Thursday, June 4th at 11 a.m. EDT
GenVec To Present At The 27th Annual ROTH Conference
Webcast Presentation Scheduled for Monday, March 9th at 12 Noon PST
GenVec To Present At The 17th Annual BIO CEO & Investor Conference
Webcast Presentation scheduled for Monday, February 9th at 1:00 p.m. EST
Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium
Sustained Immune Responses Protecting the Lung and Nose Against RSV Challenge Seen
3 Stocks Pushing The Drugs Industry Lower
TheStreet highlights 3 stocks pushing the Drugs industry lower today.
Why GenVec (GNVC) Stock Is Up In Aftermarket Trading
Shares of GenVec (GNVC) were up 12.83% to $2.99 in aftermarket trading Thursday.
